Atlas Trials

Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma

RecordFirmDate
Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors (NCT04260009)Takeda2020-09-01

Track Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.